OOIR: Observatory of International Research

Papers

(The median citation count of Expert Review of Proteomics is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
An overview of multiplexed analyses of CAR T-cell therapies: insights and potential	62
The path to anti-vector vaccines: current advances and limitations in proteomics and bioinformatics	43
Proteomics in support of immunotherapy: contribution to model-based precision medicine	42
How can proteomics help solve the lack of biomarkers to aid in the early diagnosis of motor neuron disease (MND)?	36
Proteomic profiling and network biology of colorectal cancer liver metastasis	30
Proteomic insights into the extracellular matrix: a focus on proteoforms and their implications in health and disease	30
Oncoproteomic profiling of AML: moving beyond genomics	29
Cutaneous leishmaniasis: multiomics approaches to unravel the role of immune cells checkpoints	29
Omics and rare diseases: challenges, applications, and future perspectives	27
The interdependence of machine learning and LC-MS approaches for an unbiased understanding of the cellular immunopeptidome	27
The role of proteomics in the multiplexed analysis of gene alterations in human cancer	25
Breast cancer glycan biomarkers: their link to tumour cell metabolism and their perspectives in clinical practice	24
The method developer’s guide to oligonucleotide design	23
Mapping the human brain proteome: opportunities, challenges, and clinical potential	21
Protein lysine acetylation and its role in different human pathologies: a proteomic approach	20
A computational method for the prediction and functional analysis of potential Mycobacterium tuberculosis adhesin-related proteins	19
Positional proteomics: is the technology ready to study clinical cohorts?	19
LC-MS/MS: A sensitive and selective analytical technique to detect COVID-19 protein biomarkers in the early disease stage	19
An overview of lipidomics utilizing cadaver derived biological samples	18
Chondrocyte protein co-synthesis network analysis links ECM mechanosensing to metabolic adaptation in osteoarthritis	18
Advancing kidney transplant outcomes: the role of urinary proteomics in graft function monitoring and rejection detection	18
Utilizing databases for astrocyte secretome research	17
Proteomic tools to study phosphorylation of intrinsically disordered proteins	16
Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology	14
Optimization of glycopeptide enrichment techniques for the identification of clinical biomarkers	14

Role of structural disorder in the multi-functionality of flavivirus proteins	13
Proteogenomic profiling of acute myeloid leukemia to identify therapeutic targets	13
Replication of single-cell proteomics data reveals important computational challenges	12
A Galaxy of informatics resources for MS-based proteomics	12
Evolution of proteomics technologies for understanding respiratory syncytial virus pathogenesis	11
Recent advances in mass spectrometry for the detection of doping	11
Unravelling disease complexity: integrative analysis of multi-omic data in clinical research	10
T cell population size control by coronin 1 uncovered: from a spot identified by two-dimensional gel electrophoresis to quantitative proteomics	9
Rebellion of the deregulated regulators: What is the clinical relevance of studying intrinsically disordered proteins?	9
Analyzing the glial proteome in Alzheimer’s disease	9
Integrated metabolomics and proteomics analysis of plasma lipid metabolism in Parkinson’s disease	9
Proteomic interrogation of the human olfactory system: the road ahead	9
Advances in the clinical use of metaproteomics	8
Advances in the proteomic profiling of the matrisome and adhesome	8
Characterization of anticancer drug resistance by reverse-phase protein array: new targets and strategies	7
How to maximize power for differential expression analysis in discovery omics through experimental design	7
Salivary metabolomics in early detection of oral squamous cell carcinoma – a meta-analysis	7
How glycomic studies can impact on prostate cancer	7
The use of urine peptidomics to define dietary gluten peptides from patients with celiac disease and the clinical relevance	7
Interaction and regulation of the mitochondrial proteome – in health and disease	6
New insights into human prefrontal cortex aging with a lipidomics approach	6
Glycosylation in cancer as a source of biomarkers	6
Tackling reproducibility: lessons for the proteomics community	6
Molecular markers for cervical cancer screening	6
Revisiting the antigen markers of vector-borne parasitic diseases identified by immunomics: identification and application to disease control	6
Evaluation of a ‘plug and play’ nanoflow liquid chromatography system for MS-based proteomic characterization of clinical FFPE specimens	6
Proteomics in the study of female fertility: an update	5
The role of E3 ubiquitin ligase in multiple myeloma: potential for cereblon E3 ligase modulators in the treatment of relapsed/refractory disease	5
Proteomic profiling of oral squamous cell carcinoma tissues reveals altered immune-related proteins: implications for personalized therapy	5
Metabolomics in diabetes mellitus: clinical insight	5
Proteomic profiling of carbonic anhydrase CA3 in skeletal muscle	5
Urine proteomics in cardiovascular disease: advances in biomarker discovery and clinical applications	5
Recent implementations of data-independent acquisition for cancer biomarker discovery in biological fluids	5
Patient-responsive protein biomarkers for cartilage degeneration and repair identified in the infrapatellar fat pad	5
How valuable can proteogenomics be in clinical breast cancer research?	4
Mass spectrometry based metabolomics for small molecule metabolites mining and confirmation as potential biomarkers for schistosomiasis – case of the Okavango Delta communities in Botswana	4
Role of protein deimination in cardiovascular diseases: potential new avenues for diagnostic and prognostic biomarkers	4
AlphaFold and what is next: bridging functional, systems and structural biology	4
Metabolomics studies in cushing’s syndrome: recent developments and perspectives	4
Neuroproteomic mapping of kinases and their substrates downstream of acetylcholine: finding and implications	4
How can proteomics be incorporated into the management of atrial fibrillation?	4
Reverse phase protein arrays in acute leukemia: investigative and methodological challenges	4
Genetic signatures of suicide attempt behavior: insights and applications	4
Rise of the SARS-CoV-2 Variants: can proteomics be the silver bullet?	4
Blood plasma proteomic markers of Alzheimer’s disease, current status and application prospects	3
Glycoproteomic contributions to hepatocellular carcinoma research: a 2023 update	3
Mapping the human sperm proteome – novel insights into reproductive research	3
Recent progress in quantitative phosphoproteomics	3
Immobilized metal ion affinity chromatography: waltz of metal ions and biomacromolecules	3
Proteolytic signaling in cancer	3

Oncoproteins E6/E7 of the human papillomavirus types 16 & 18 synergize in modulating oncogenes and tumor suppressor proteins in colorectal cancer	3
Mass Spectrometry Imaging of Fibroblasts: Promise and Challenge	3
A proteome-level view of brain tumors for a better understanding of novel diagnosis, prognosis, and therapy	3
Single-cell omics techniques to elucidate cell-to-cell variability in signalling cascades involved in human diseases	3
Phosphoproteomics: a valuable tool for uncovering molecular signaling in cancer cells	3
Mass Spectrometry-based Biomarkers for Knee Osteoarthritis: A Systematic Review	3
Proteomic scrutiny of nasal microbiomes: implications for the clinic	2
Proteomics and phosphoproteomics analysis of tissues for the reoccurrence prediction of colorectal cancer	2
Protein markers of spermatogenesis and their potential use in the management of azoospermia	2
Emerging protein sequencing technologies: proteomics without mass spectrometry?	2
Proteomic approaches for untangling pharmacological targets in acute myelogenous leukemia	2
Proteomics applications in next generation induced pluripotent stem cell models	2
A complete proteomic profile of human and bovine milk exosomes by liquid chromatography mass spectrometry	2
Two decades of advances in sequence-based prediction of MoRFs, disorder-to-order transitioning binding regions	2
Schistosome proteomics: updates and clinical implications	2
Noninvasive urine metabolomics of prostate cancer and its therapeutic approaches: a current scenario and future perspective	2
Laser Capture Proteomics: spatial tissue molecular profiling from the bench to personalized medicine	2
Spatial Proteomics towards cellular Resolution	2
Identifying therapeutic strategies for triple-negative breast cancer via phosphoproteomics	2
Empowering women and addressing underrepresentation in the field of mass spectrometry	2
Understanding the age-related alterations in the testis-specific proteome	2
Cellular thermal shift assay: an approach to identify and assess protein target engagement	2
Human bronchial-pulmonary proteomics in coronavirus disease 2019 (COVID-19) pandemic: applications and implications	2
Deciphering a proteomic signature for the early detection of breast cancer from breast milk: the role of quantitative proteomics	2
Protein biomarkers for radiation injury and testing of medical countermeasure efficacy: promises, pitfalls, and future directions	2